FORTEO (teriparatide)


Drug overview for FORTEO (teriparatide):

Generic name: TERIPARATIDE (TER-i-PAR-a-tide)
Drug class: Osteoporosis Agents
Therapeutic class: Endocrine

Teriparatide, a biosynthetic (recombinant DNA origin) peptide fragment of human parathyroid hormone (parathormone, PTH), is an osteoanabolic agent.

No enhanced Uses information available for this drug.
DRUG IMAGES
  • FORTEO 600 MCG/2.4 ML PEN INJ
    FORTEO 600 MCG/2.4 ML PEN INJ
The following indications for FORTEO (teriparatide) have been approved by the FDA:

Indications:
Glucocorticoid-induced osteoporosis
Osteoporosis in male patient
Osteoporosis in postmenopausal woman at high risk for fracture


Professional Synonyms:
Glucocorticoid hormone-induced osteoporosis
Glucocorticoid induced osteoporosis
Glycocorticoid-induced osteoporosis
Osteoporosis in men
Postmenopausal osteoporosis in woman with high fracture risk
Postmenopausal osteoporosis with high fracture risk